Company Overview
American HealthCare Capital is pleased to exclusively introduce a Clinical Trial Research company for sale in Southern California. Founded in 2013, this multi-specialty clinical research center operates out of a 7,200 square foot facility and has successfully conducted more than 200 Phase 2–4 clinical trials across geriatric, adult, adolescent, and pediatric populations. The organization is led by five Principal Investigators, each specializing in a distinct therapeutic area. The President and owner is an Adult and Geriatric Psychiatrist who specializes in CNS disorders with a focus on the diagnosis and treatment of dementia. Additional investigators include a board-certified Cardiologist with over 40 years of clinical research experience and more than 300 trials completed, a Primary Care/Dermatology physician and a board-certified Dermatologist—each with over 15 years of research experience—and a General Surgeon with 25 years of research experience and participation in over 150 trials. The business is CLIA-certified and maintains a database of more than 18,000 active participants.
Location and Facility
The center is strategically located in Southern California near major freeway systems. The facility features five exam rooms, four dedicated infusion rooms, a CLIA-certified lab, and four multipurpose rooms utilized for exams, monitoring, and ratings.
Financial Overview
The company has maintained consistent profitability and expects renewed growth in 2026 following early 2025 adjustments.
- 2023 Revenue: $3.34 million; Adjusted EBITDA: $511,000
- 2024 Revenue: $3.2 million; Adjusted EBITDA: $658,000
- 2025 Projected Revenue: $2.5 million; Adjusted EBITDA: $100,000
Growth Opportunities
Expansion opportunities include marketing to non-referring physicians, hiring a dedicated business development and outreach professional, and leveraging the existing participant database for targeted recruitment. The facility can accommodate two to three additional coordinators and support staff to meet growing demand.
Staff and Exit Plan
The company employs a full complement of staff, including a strong leadership team composed of directors overseeing regulatory affairs, clinical operations, quality assurance, marketing, and pharmacy. The founder will remain available to assist with a smooth transition with the flexibility to offer extended guidance as the company embarks on this promising new venture.
Asking Price
The asking price for this opportunity is $2 million.
